Sylics is a trade name of Synaptologics BV
Sylics is a private Dutch company founded on the initiative of a small group of research opinion leaders from the Neuroscience Campus Amsterdam in 2007. To accommodate its steady growth, Sylics moved to it's current facilities in Bilthoven, The Netherlands. In January 2023, Sylics became part of the InnoSer group.
Research solutions in neuroscience
Sylics offers innovative research solutions for preclinical neuroscience. We specialize in developing and employing customized mouse models and behavioural tests for neurological and psychiatric diseases, with a strong focus on neurodegeneration and schizophrenia. Highly efficient, sensitive and reproducible screening for behavioural deficits is supported by our automated screening platform and proprietary analysis software AHCODA™. For more than 12 years, we successfully characterized dozens of novel mouse models, and determined compound efficacy and side-effects in numerous projects for academia, biotech, and food industry clients.
Sylics runs behavioural tests in well-separated rooms that are permanently equipped with specific behavioural setups for conventional and automated screening.
Our experienced technicians are dedicated to an optimal execution of all behavioural experiments. Behavioural tests are constantly being developed and optimized by our scientists.